Integrated multi-omics analysis of the clinical relevance and potential regulatory mechanisms of splicing factors in hepatocellular carcinoma

References

• Dvinge H, Bradley RK. Widespread intron retention diversifies most cancer transcriptomes. Genome Med. 2015;7:45.
   PubMed Web of Science ®Google Scholar
• Kim HK, Pham MHC, Ko KS, et al. Alternative splicing isoforms in health and disease. Pflugers Arch. 2018;470:995–1016.
   PubMed Web of Science ®Google Scholar
• Danan-Gotthold M, Golan-Gerstl R, Eisenberg E, et al. Identification of recurrent regulated alternative splicing events across human solid tumors. Nucleic Acids Res. 2015;43:5130–5144.
   PubMed Web of Science ®Google Scholar
• Karni R, De Stanchina E, Lowe SW, et al. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol. 2007;14:185–193.
   PubMed Web of Science ®Google Scholar
• Jia R, Li C, McCoy JP, et al. SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance. Int J Biol Sci. 2010;6:806–826.
   PubMed Web of Science ®Google Scholar
• Golan-Gerstl R, Cohen M, Shilo A, et al. Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma. Cancer Res. 2011;71:4464–4472.
   PubMed Web of Science ®Google Scholar
• Valery PC, Laversanne M, Clark PJ, et al. Projections of primary liver cancer to 2030 in 30 countries worldwide. Hepatology. 2017.
   PubMed Web of Science ®Google Scholar
• Sanduzzi-Zamparelli M, Diaz-Gonzalez A, Reig M. New systemic treatments in advanced hepatocellular carcinoma. Liver Transpl. 2018.
   Web of Science ®Google Scholar
• Tremblay MP, Armero VE, Allaire A, et al. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma. BMC Genomics. 2016;17:683.
   PubMed Web of Science ®Google Scholar
• Vanderwalde A, Spetzler D, Xiao N, et al. Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients. Cancer Med. 2018;7:746–756.
   PubMed Web of Science ®Google Scholar
• Seiler M, Peng S, Agrawal AA, et al. Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types. Cell Rep. 2018;23:282–96 e4.
   PubMed Web of Science ®Google Scholar
• Hegele A, Kamburov A, Grossmann A, et al. Dynamic protein-protein interaction wiring of the human spliceosome. Mol Cell. 2012;45:567–580.
   PubMed Web of Science ®Google Scholar
• Barbosa-Morais NL, Carmo-Fonseca M, Aparicio S. Systematic genome-wide annotation of spliceosomal proteins reveals differential gene family expansion. Genome Res. 2006;16:66–77.
   PubMed Web of Science ®Google Scholar
• Cvitkovic I, Jurica MS. Spliceosome database: a tool for tracking components of the spliceosome. Nucleic Acids Res. 2013;41:D132–41.
   PubMed Web of Science ®Google Scholar
• Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572–1573.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–287.
   PubMed Web of Science ®Google Scholar
• Walter W, Sanchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31:2912–2914.
   PubMed Web of Science ®Google Scholar
• Koboldt DC, Zhang Q, Larson DE, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22:568–576.
   PubMed Web of Science ®Google Scholar
• Ryan M, Wong WC, Brown R, et al. TCGASpliceSeq a compendium of alternative mRNA splicing in cancer. Nucleic Acids Res. 2016;44:D1018–22.
   PubMed Web of Science ®Google Scholar
• Gamazon ER, Stranger BE. The impact of human copy number variation on gene expression. Brief Funct Genomics. 2015;14:352–357.
   PubMed Web of Science ®Google Scholar
• Zemach A, McDaniel IE, Silva P, et al. Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science. 2010;328:916–919.
   PubMed Web of Science ®Google Scholar
• Huang ZC, Li H, Sun ZQ, et al. Distinct prognostic roles of HSPB1 expression in non-small cell lung cancer. Neoplasma. 2018;65:161–166.
   PubMed Web of Science ®Google Scholar
• Luk JM, Lam CT, Siu AF, et al. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics. 2006;6:1049–1057.
   PubMed Web of Science ®Google Scholar
• Cheng J, Lv Z, Weng X, et al. Hsp27 acts as a master molecular chaperone and plays an essential role in hepatocellular carcinoma progression. Digestion. 2015;92:192–202.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tao X, Jin G, et al. A targetable molecular chaperone Hsp27 confers aggressiveness in hepatocellular carcinoma. Theranostics. 2016;6:558–570.
   PubMed Web of Science ®Google Scholar
• Zhang T, Ma Z, Liu L, et al. DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/beta-catenin pathway. Cell Death Dis. 2018;9:675.
   PubMed Web of Science ®Google Scholar
• Naboulsi W, Megger DA, Bracht T, et al. Quantitative tissue proteomics analysis reveals versican as potential biomarker for early-stage hepatocellular carcinoma. J Proteome Res. 2016;15:38–47.
   PubMed Web of Science ®Google Scholar
• Dang H, Takai A, Forgues M, et al. Oncogenic activation of the RNA binding protein NELFE and MYC signaling in hepatocellular carcinoma. Cancer Cell. 2017;32:101–14 e8.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang PS, Wang BG, et al. Genomewide identification of a novel six-LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma. Cancer Med. 2018. DOI:10.1002/cam4.1854
   Web of Science ®Google Scholar
• Long J, Zhang L, Wan X, et al. A four-gene-based prognostic model predicts overall survival in patients with hepatocellular carcinoma. J Cell Mol Med. 2018;22:5928–5938.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Electronic address wbe, Cancer Genome Atlas Research N. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 2017;169:1327–41 e23.
   PubMed Web of Science ®Google Scholar
• Li X, Xu W, Kang W, et al. Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features. Theranostics. 2018;8:1740–1751.
   PubMed Web of Science ®Google Scholar
• Zack TI, Schumacher SE, Carter SL, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet. 2013;45:1134–1140.
   PubMed Web of Science ®Google Scholar
• Yang X, Han H, De Carvalho DD, et al. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell. 2014;26:577–590.
   PubMed Web of Science ®Google Scholar
• Mao S, Li Y, Lu Z, et al. Survival-associated alternative splicing signatures in esophageal carcinoma. Carcinogenesis. 2018.
   Web of Science ®Google Scholar
• Xiong Y, Deng Y, Wang K, et al. Profiles of alternative splicing in colorectal cancer and their clinical significance: a study based on large-scale sequencing data. EBioMedicine. 2018;36:183–195.
   PubMed Web of Science ®Google Scholar
• Huang ZG, He RQ, Mo ZN. Prognostic value and potential function of splicing events in prostate adenocarcinoma. Int J Oncol. 2018;53:2473–2487.
   PubMed Web of Science ®Google Scholar
• Zhang J, Manley JL. Misregulation of pre-mRNA alternative splicing in cancer. Cancer Discov. 2013;3:1228–1237.
   PubMed Web of Science ®Google Scholar
• Ryan MC, Cleland J, Kim R, et al. SpliceSeq: a resource for analysis and visualization of RNA-Seq data on alternative splicing and its functional impacts. Bioinformatics. 2012;28:2385–2387.
   PubMed Web of Science ®Google Scholar